StockSelector.com
  Research, Select, & Monitor Tuesday, September 22, 2020 4:17:58 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Tandem Diabetes Care, Inc.$105.32($1.08)(1.02%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Tandem Diabetes Care, Inc. has an overall rank of 3062 out of 7756 stocks based on 11 positive rankings and 9 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for Tandem Diabetes Care is $1,316.00. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Tandem Diabetes Care is ranked 135.
PEGValue
Tandem Diabetes Care has a PEG Value of $1,104.00. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 948.23% in the next year. Among companies with a PEG Value above the current stock price, Tandem Diabetes Care is ranked 137.
Historic Revenue Growth
Tandem Diabetes Care rank is 168
Positive Guidance
Within the past 90 days Tandem Diabetes Care has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Estimated Revenue Growth
Tandem Diabetes Care rank is 371
Beat Whisper
According to EarningsWhispers.com, Tandem Diabetes Care beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Target Prices
The average analysts' target price is $120.00 for Tandem Diabetes Care using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Tandem Diabetes Care is ranked 884.
Debt-to-Equity
Tandem Diabetes Care rank is 1331
Low Put/Call
Tandem Diabetes Care has a low Put/Call ratio of 0.45 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Tandem Diabetes Care is ranked 1500.
Up EPS Surprise
Tandem Diabetes Care beat the consensus earnings estimate when it last reported quarterly earnings.
90 Day Gain
Tandem Diabetes Care rank is 1963
Negative Rankings
Price-to-Book
Tandem Diabetes Care rank is 152
Negative Cash Growth
Tandem Diabetes Care rank is 201
Price-to-Sales
Tandem Diabetes Care rank is 431
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Tandem Diabetes Care is ranked 745.
Negative ROE
Tandem Diabetes Care rank is 1253
Negative Net Margin
Tandem Diabetes Care rank is 1318
High vPut/Call
Tandem Diabetes Care has a high Put/Call ratio of 0.88 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Tandem Diabetes Care is ranked 1322.
Negative ROA
Tandem Diabetes Care rank is 1410
10 Day Loss
Tandem Diabetes Care rank is 2974







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.